What they were paid
Indivior Pharmaceuticals Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $39,920 | $0 | $0 | $0 | $39,920 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Indivior Pharmaceuticals, Inc. DEF 14A filed March 27, 2026, accession 0001104659-26-035480, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Indivior Pharmaceuticals pays directors a $250,000 cash retainer and $87,500 in Shares (NED Share Program).
The rest of the Indivior Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Barbara Ryan | Independent Director | $220,466 |
| Daniel Ninivaggi | Independent Director | $186,697 |
| David Wheadon | Chair of the Board | $441,027 |
| Joe Ciaffoni | Director | $0 |
| Juliet Thompson | Independent Director | $251,563 |
| Keith Humphreys | Independent Director | $196,785 |
| Mark Stejbach | Independent Director | $217,511 |
| Tony Kingsley | Independent Director | $140,000 |
The full Indivior Pharmaceuticals compensation record
free company briefThis page is one director within Indivior Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat